Hyloris Pharmaceuticals SA

ENXTBR:HYL Stock Report

Mkt Cap: €344.4m

Hyloris Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Stijn Van Rompay

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership36.4%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Do Institutions Own Hyloris Pharmaceuticals SA (EBR:HYL) Shares?

Mar 08
Do Institutions Own Hyloris Pharmaceuticals SA (EBR:HYL) Shares?

CEO

Stijn Van Rompay (47 yo)

no data

Tenure

Mr. Stijn Van Rompay is a Co-Founder, Chief Executive Officer and Director Hyloris Pharmaceuticals SA. He was the Chief Executive Officer of Alter Pharma, a high-growth pharmaceutical company focused on th...